19.18

3.67% -0.73

Relay Therapeutics Inc (RLAY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RLAY Giù? Forum Previsione

Precedente Chiudi:

$19.91

Aprire:

$19.95

Volume 24 ore:

2.30M

Relative Volume:

0.57

Capitalizzazione di mercato:

$4.18B

Reddito:

$10.68M

Utile/perdita netta:

$-272.71M

Rapporto P/E:

-12.26

EPS:

-1.565

Flusso di cassa netto:

$-213.38M

1 W Prestazione:

+2.40%

1M Prestazione:

+20.78%

6M Prestazione:

+158.84%

1 anno Prestazione:

+448.00%

Intervallo 1D:

$19.15

$20.39

Intervallo di 1 settimana:

$18.40

$20.39

Portata 52W:

$3.025

$20.79

Relay Therapeutics Inc Stock (RLAY) Company Profile

Nome

Relay Therapeutics Inc

Settore

Healthcare (1089)

Industria

Biotechnology (603)

Telefono

617-370-8837

Indirizzo

60 HAMPSHIRE STREET, CAMBRIDGE

Dipendente

192

Cinguettio

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

RLAY's Discussions on Twitter

Compare RLAY vs VRTX, REGN, ARGX, RVMD, ALNY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RLAY Relay Therapeutics Inc	19.18	4.18B	10.68M	-272.71M	-213.38M	-1.565
VRTX Vertex Pharmaceuticals Inc	480.50	121.95B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	672.15	70.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.19	52.94B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	180.39	38.35B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	272.67	36.40B	4.29B	577.22M	641.34M	4.2086

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-26	Aggiornamento	Oppenheimer	Perform → Outperform
2025-12-12	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2025-09-04	Ripresa	Guggenheim	Buy
2025-04-17	Iniziato	Wells Fargo	Equal Weight
2024-09-10	Ripresa	Goldman	Buy
2024-09-10	Aggiornamento	Jefferies	Hold → Buy
2024-09-10	Downgrade	Oppenheimer	Outperform → Perform
2024-05-10	Aggiornamento	Barclays	Equal Weight → Overweight
2023-04-20	Aggiornamento	Jefferies	Underperform → Hold
2023-04-19	Aggiornamento	Raymond James	Outperform → Strong Buy
2023-04-13	Iniziato	Raymond James	Outperform
2023-02-03	Iniziato	Oppenheimer	Outperform
2022-09-30	Iniziato	Barclays	Equal Weight
2022-09-02	Iniziato	Stifel	Buy
2022-06-06	Iniziato	Jefferies	Underperform
2022-02-01	Iniziato	Berenberg	Buy
2021-07-21	Iniziato	BofA Securities	Buy
2020-12-15	Reiterato	H.C. Wainwright	Buy
2020-12-08	Iniziato	JMP Securities	Mkt Outperform
2020-11-05	Iniziato	H.C. Wainwright	Buy
2020-08-10	Iniziato	Cowen	Outperform
2020-08-10	Iniziato	Goldman	Buy
2020-08-10	Iniziato	Guggenheim	Buy
2020-08-10	Iniziato	JP Morgan	Neutral

Mostra tutto

Relay Therapeutics Inc Borsa (RLAY) Ultime notizie

Jul 19, 2026

Certain Stock Options of Relay Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 20-JUL-2026. - marketscreener.com

Jul 19, 2026

Certain Common Stock of Relay Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 20-JUL-2026. - marketscreener.com

Jul 19, 2026

Jul 16, 2026

Why Is RLAY Stock Rising Today? - Stocktwits

Jul 16, 2026

Relay Therapeutics (RLAY) Edges Higher as Stock Tests Key Resistance at $20.68High Volume Stocks - dars.gov.et

Jul 16, 2026

Canaccord initiates Relay Therapeutics stock with buy rating - Investing.com

Jul 16, 2026

Canaccord initiates Relay Therapeutics stock with buy rating By Investing.com - Investing.com UK

Jul 16, 2026

RLAY Initiated Coverage by Canaccord Genuity -- Price Target Ann - GuruFocus

Jul 16, 2026

CCORF Initiates Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $29 - Moomoo

Jul 16, 2026

Jul 14, 2026

RLAY Stock Declines Pre-Market After $175M Offering — Despite Fresh Bullish Calls On Relay's Zovegalisib - Stocktwits

Jul 14, 2026

Jul 11, 2026